Fan Teng, Huang Yuanyuan, Liu Zeyu, Huang Jinsheng, Ke Bin, Rong Yuming, Qiu Huijuan, Zhang Bei
TCM&VIP Department, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Drug Des Devel Ther. 2024 Apr 10;18:1115-1131. doi: 10.2147/DDDT.S394287. eCollection 2024.
The ChaiShao Shugan Formula (CSSGF) is a traditional Chinese medicine formula with recently identified therapeutic value in triple-negative breast cancer (TNBC). This study aimed to elucidate the underlying mechanism of CSSGF in TNBC treatment.
TNBC targets were analyzed using R and data were from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The major ingredients and related protein targets of CSSGF were explored via the Traditional Chinese Medicine Systems Pharmacology database, and an ingredient-target network was constructed via Cytoscape to identify hub genes. The STRING database was used to construct the PPI network. GO and KEGG enrichment analyses were performed via R to obtain the main targets. The online tool Kaplan‒Meier plotter was used to identify the prognostic genes. Molecular docking was applied to the core target genes and active ingredients. MDA-MB-231 and MCF-7 cell lines were used to verify the efficacy of the various drugs.
A total of 4562 genes were screened as TNBC target genes. The PPI network consisted of 89 nodes and 845 edges. Our study indicated that quercetin, beta-sitosterol, luteolin and catechin might be the core ingredients of CSSGF, and EGFR and c-Myc might be the latent therapeutic targets of CSSGF in the treatment of TNBC. GO and KEGG analyses indicated that the anticancer effect of CSSGF on TNBC was mainly associated with DNA binding, transcription factor binding, and other biological processes. The related signaling pathways mainly involved the TNF-a, IL-17, and apoptosis pathways. The molecular docking data indicated that quercetin, beta-sitosterol, luteolin, and catechin had high affinity for EGFR, JUN, Caspase-3 and ESR1, respectively. In vitro, we found that CSSGF could suppress the expression of c-Myc or promote the expression of EGFR. In addition, we found that quercetin downregulates c-Myc expression in two BC cell lines.
This study revealed the effective ingredients and latent molecular mechanism of action of CSSGF against TNBC and confirmed that quercetin could target c-Myc to induce anti-BC effects.
柴芍疏肝方(CSSGF)是一种传统中药方剂,最近被发现对三阴性乳腺癌(TNBC)具有治疗价值。本研究旨在阐明CSSGF治疗TNBC的潜在机制。
使用R分析TNBC靶点,数据来自癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)。通过中药系统药理学数据库探索CSSGF的主要成分和相关蛋白靶点,并通过Cytoscape构建成分-靶点网络以识别枢纽基因。使用STRING数据库构建蛋白质-蛋白质相互作用(PPI)网络。通过R进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析以获得主要靶点。使用在线工具Kaplan-Meier绘图仪识别预后基因。将分子对接应用于核心靶基因和活性成分。使用MDA-MB-231和MCF-7细胞系验证各种药物的疗效。
共筛选出4562个基因作为TNBC靶基因。PPI网络由89个节点和845条边组成。我们的研究表明,槲皮素、β-谷甾醇、木犀草素和儿茶素可能是CSSGF的核心成分,表皮生长因子受体(EGFR)和c-Myc可能是CSSGF治疗TNBC的潜在治疗靶点。GO和KEGG分析表明,CSSGF对TNBC的抗癌作用主要与DNA结合、转录因子结合和其他生物学过程有关。相关信号通路主要涉及肿瘤坏死因子-α(TNF-α)、白细胞介素-17(IL-17)和凋亡通路。分子对接数据表明,槲皮素、β-谷甾醇、木犀草素和儿茶素分别对EGFR、JUN、半胱天冬酶-3(Caspase-3)和雌激素受体1(ESR1)具有高亲和力。在体外,我们发现CSSGF可以抑制c-Myc的表达或促进EGFR的表达。此外,我们发现槲皮素下调两种乳腺癌细胞系中c-Myc的表达。
本研究揭示了CSSGF抗TNBC的有效成分和潜在分子作用机制,并证实槲皮素可靶向c-Myc诱导抗乳腺癌作用。